The Discounted Cash Flow (DCF) valuation of Zevra Therapeutics Inc (ZVRA) is 25.08 USD. With the latest stock price at 9.40 USD, the upside of Zevra Therapeutics Inc based on DCF is 166.8%.
Based on the latest price of 9.40 USD and our DCF valuation, Zevra Therapeutics Inc (ZVRA) is a buy. buying ZVRA stocks now will result in a potential gain of 166.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 8.6% | 7.5% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 20.67 - 32.19 | 25.08 |
| Upside | 119.9% - 242.4% | 166.8% |